The European Independent Medical Cannabis Company
Bringing together cutting-edge scientific research with the latest innovations in cannabis cultivation, extraction and production.
The European Independent Medical Cannabis Company
Bringing together cutting-edge scientific research with the latest innovations in cannabis cultivation, extraction and production.
Medical Cannabis
EMMAC is bringing together the latest science and research into the medical benefits of cannabis with pioneering cultivation, extraction and production to establish itself as the European leader in the production and supply of medical cannabis.
EMMAC announces pioneering research collaboration with Imperial College London
The partnership between EMMAC and Imperial College London has been forged to deliver a long-term comprehensive research programme designed to shape the future of the medical cannabis therapeutic industry.
EMMAC’s European Operations
EMMAC has developed unique supply and distribution partnerships across Europe to establish itself not only as a thought leader at the very forefront of research into the medical benefits of cannabis but also a European leader in the production and supply of medical cannabis, hemp and other derivative products.
EMMAC Across Europe
ISRAEL
Events & Press Releases
22nd January 2019Acquisition of a majority interest in Medalchemy, a GMP certified laboratory, in Alicante Spain
Medalchemy, a technology-based manufacturing company located on the premises of the University of Alicante, has more than a decade of experience in the research, development and manufacture of active pharmaceutical ingredients (APIs) and has submitted license applications to import, research, manufacture and export medical cannabis.
Read more »
15th January 2019Board and Leadership Appointments
Dr Barbara Pacchetti as Chief Scientific Officer and Dr Mikael Sodergren as Research Director Recognised scientific pioneers to drive research and innovation to shape the global future of medicinal
Read more »
10th January 2019Research collaboration with Imperial College London
A pre-clinical and clinical research programme to investigate cannabis-based medicinal products aimed to directly benefit patients. EMMAC, the European independent medical cannabis company, is pleased to announce a research
Read more »Contact Us
